Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 8/20 | 0.82 |
| ▸ | FAAH | O00519 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | CNR2 | P34972 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.68 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.68 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.66 |
| ▸ | HPGD | P15428 | 1/20 | 0.66 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12318762 | 0.90 | CNR1 (0.79) | CNR1FAAHALDH1A1CNR2MEN1 | |
| SCHEMBL15479139 | 0.90 | CNR1 (1.00) | CNR1FAAHALDH1A1CNR2MEN1 | |
| SCHEMBL2493620 | 0.90 | CNR1 (0.79) | CNR1FAAHALDH1A1CNR2MEN1 | |
| SCHEMBL232709 | 0.90 | CNR1 (1.00) | CNR1FAAHALDH1A1CNR2MEN1 | |
| SCHEMBL232708 | 0.90 | CNR1 (1.00) | CNR1FAAHALDH1A1CNR2MEN1 | |
| SCHEMBL14864049 | 0.90 | CNR1 (0.78) | CNR1FAAHALDH1A1CNR2MEN1 | |
| SCHEMBL13767988 | 0.89 | CNR1 (1.00) | CNR1FAAHALDH1A1CNR2MEN1 | |
| SCHEMBL1228841 | 0.89 | CNR1 (1.00) | CNR1FAAHALDH1A1CNR2MEN1 | |
| SCHEMBL8052707 | 0.89 | CNR1 (1.00) | CNR1FAAHALDH1A1CNR2MEN1 | |
| SCHEMBL15198285 | 0.88 | CNR1 (0.69) | CNR1ALDH1A1MEN1KMT2ABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160129122-A1 | FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. | 2016-05-12 | — | — | US | disclosed |
| US-20140288025-A1 | FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2014-09-25 | — | — | US | disclosed |
| US-20130244966-A1 | FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-8445707-B1 | Compound, composition and uses thereof | Krisani Biosciences (P) Ltd. (IN) | 2013-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130244966-A1 | FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES | FABP1, FABP2, HAVCR2 | CNR1 2600/4885FAAH 81/4885ALDH1A1 1235/4885 |
| US-20140288025-A1 | FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES | FABP1, FABP2, HAVCR2 | CNR1 2600/4885FAAH 81/4885ALDH1A1 1235/4885 |
| US-20160129122-A1 | FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES | FABP1, FABP2, HAVCR2 | CNR1 2600/4885FAAH 81/4885ALDH1A1 1235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.